Centessa Pharmaceuticals plc
Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.
CNTA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US1523091007
- LEI:
- Country:
- United States of America
- Address:
- 3RD FLOOR, ALTRINCHAM, CHESHIRE
- Website:
- https://www.centessa.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company focused on discovering and developing transformational medicines for patients with unmet medical needs. The company leverages a data-driven Research & Development model to advance a portfolio of innovative assets. Its lead program is a potential best-in-class orexin receptor 2 (OX2R) agonist being developed for the treatment of sleep-wake disorders. The company's pipeline also includes programs targeting other conditions, such as hemophilia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Centessa Pharmaceuticals plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Centessa Pharmaceuticals plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Centessa Pharmaceuticals plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
